Ponoi Capital II, LP, 10% Owner, Ten Percent Owner Other at NGM BIOPHARMACEUTICALS INC (NGM), bought 599,944 shares at $11.63 ($7.1M) on 2020-03-23, disclosed to the SEC on 2020-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.63 | 170,387 | $2.0M | 27.8% |
| 2 | $11.63 | 170,387 | $2.0M | 27.8% |
| 3 | $12.22 | 128,377 | $1.6M | 22.0% |
| 4 | $12.22 | 128,377 | $1.6M | 22.0% |
| 5 | $12.49 | 2,416 | $30K | 0.4% |
| Total | $11.89 avg | 599,944 |
| $7.1M |
| 100% |
| Filing → |
| NGM | BUY | 2022-10-27 | $1.2M | — | Filing → |
| NGM | BUY | 2022-05-17 | $842K | — | Filing → |
| RAPT | SELL | 2021-09-29 | $578K | — | Filing → |